Improvement in mood, oxidative stress, fatigue, and insomnia following supplementary management with Robuvit ®.
CONCLUSIONS: The observed decrease in OS levels in our patients is probably the result of the antioxidative activity of Robuvit®, and, more precisely, of its active metabolites, the urolithins and ellagic acid.
PMID: 29938480 [PubMed - in process]
Source: Journal of Neurosurgical Sciences - Category: Neurosurgery Tags: J Neurosurg Sci Source Type: research
More News: Alzheimer's | Brain | Chronic Fatigue Syndrome | France Health | Insomnia | Mitochondrial Disease | Neurology | Neurosurgery | Parkinson's Disease